Cargando…

Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer

BACKGROUND: Lung cancer survival remains poor. The introduction of Intensity-Modulated Radiotherapy (IMRT) allows treatment of more complex tumours as it improves conformity around the tumour and greater normal tissue sparing. However, there is limited evidence assessing the clinical impact of IMRT....

Descripción completa

Detalles Bibliográficos
Autores principales:	Fornacon-Wood, Isabella, Chan, Clara, Bayman, Neil, Banfill, Kathryn, Coote, Joanna, Garbett, Alex, Harris, Margaret, Hudson, Andrew, Kennedy, Jason, Pemberton, Laura, Salem, Ahmed, Sheikh, Hamid, Whitehurst, Philip, Woolf, David, Price, Gareth, Faivre-Finn, Corinne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197586/ https://www.ncbi.nlm.nih.gov/pubmed/35712515 http://dx.doi.org/10.3389/fonc.2022.835844

Ejemplares similares

The evolving role of radiotherapy in non-small cell lung cancer
por: Brown, Sean, et al.
Publicado: (2019)

Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?
por: Lewis, T.S., et al.
Publicado: (2020)

Impact of small residual setup errors after image guidance on heart dose and survival in non-small cell lung cancer treated with curative-intent radiotherapy
por: Johnson-Hart, Corinne, et al.
Publicado: (2020)

The use of volunteers to implement electronic patient reported outcomes in lung cancer outpatient clinics
por: Ala-Aldeen, Kardo, et al.
Publicado: (2018)

Role of Real-World Data in Assessing Cardiac Toxicity After Lung Cancer Radiotherapy
por: Abravan, Azadeh, et al.
Publicado: (2022)

Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hype
por: Fornacon-Wood, Isabella, et al.
Publicado: (2020)

Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions
por: Banfill, Kathryn, et al.
Publicado: (2021)

Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer
por: Banfill, Kathryn, et al.
Publicado: (2022)

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic
por: Faivre-Finn, C., et al.
Publicado: (2020)

PO-1198 Changes in radical radiotherapy for lung cancer patients in the UK during the COVID-19 pandemic.
por: croxford, W., et al.
Publicado: (2021)

A novel use for routine CBCT imaging during radiotherapy to detect COVID-19
por: Clough, A., et al.
Publicado: (2022)

Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study
por: Haslett, Kate, et al.
Publicado: (2016)

Renocolic fistula secondary to curative intent extended field radiotherapy for cervical cancer
por: Thiyagarajan, Dhanalakshmi, et al.
Publicado: (2018)

P09.17 Changes in the Management of Patients Having Radical Radiotherapy in the UK During the COVID-19 Pandemic (COVID-RT Lung)
por: Banfill, K., et al.
Publicado: (2021)

Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK
por: Banfill, K., et al.
Publicado: (2022)

Radiotherapy tumor volume for limited-stage small cell lung cancer: less is more
por: Levy, Antonin, et al.
Publicado: (2020)

Patient and clinician-reported experiences of using electronic patient reported outcome measures (ePROMs) as part of routine cancer care
por: Payne, Amelia, et al.
Publicado: (2023)

Reliability and prognostic value of radiomic features are highly dependent on choice of feature extraction platform
por: Fornacon-Wood, Isabella, et al.
Publicado: (2020)

Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC
por: MacManus, Michael, et al.
Publicado: (2023)

Impact of the COVID-19 Pandemic on Radiotherapy Patterns of Practice for Curative Intent Breast Cancer Patients
por: Liao, D., et al.
Publicado: (2021)

Thoracic radiotherapy in small cell lung cancer—a narrative review
por: Levy, Antonin, et al.
Publicado: (2021)

Association between radiotherapy protocol variations and outcome in the CONVERT trial
por: Mir, Romaana, et al.
Publicado: (2022)

A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy
por: Jochems, Arthur, et al.
Publicado: (2017)

Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung)
por: Banfill, Kathryn Banfill, et al.
Publicado: (2021)

Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study
por: He, Xiaofeng, et al.
Publicado: (2018)

87: Impact of the COVID-19 Pandemic on Radiotherapy Patterns of Practice for Curative Intent Breast Cancer Patients
por: Liao, Donna, et al.
Publicado: (2021)

The survival outcome and patterns of failure in node positive endometrial cancer patients treated with surgery and adjuvant radiotherapy with curative intent
por: Rajasooriyar, Chrishanthi, et al.
Publicado: (2014)

An Italian survey on “palliative intent” radiotherapy
por: Pergolizzi, Stefano, et al.
Publicado: (2022)

Infrastructural Challenges Lead to Delay of Curative Radiotherapy in Nigeria
por: Leng, Jim, et al.
Publicado: (2020)

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
por: Mulvenna, Paula, et al.
Publicado: (2016)

203MO Changes in management for patients with lung cancer treated with radical radiotherapy during the first wave of the COVID-19 pandemic in the UK (COVID-RT Lung)
por: Banfill, K., et al.
Publicado: (2021)

Curative Radiotherapy for Locally Advanced Scalp Squamous Cell Carcinoma
por: Xing, Daniel, et al.
Publicado: (2021)

Resource-sparing curative-intent hypofractionated-accelerated radiotherapy in head and neck cancer: More relevant than ever before in the COVID era
por: Gupta, Tejpal, et al.
Publicado: (2020)

Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy
por: Burtin, Chris, et al.
Publicado: (2020)

Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: a systematic review and meta-analysis
por: David, Rowan, et al.
Publicado: (2022)

Optimising use of 4D-CT phase information for radiomics analysis in lung cancer patients treated with stereotactic body radiotherapy
por: Davey, Angela, et al.
Publicado: (2021)

Radiotherapy Combined With Androgen Deprivation for Bone Oligometastases After Primary Curative Radiotherapy for Prostate Cancer: A Retrospective Study
por: Wu, Jun-Xin, et al.
Publicado: (2016)

Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer
por: Hoffmann, Elgin, et al.
Publicado: (2021)

Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy
por: Kang, Min Kyu, et al.
Publicado: (2015)

Spontaneous Rupture of the Urinary Bladder 10 Years after Curative Radiotherapy
por: Labanaris, Apostolos P., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6bohmb18erdesd7sj8rj4vkks3